November 5, 2019 — The U.S.
Point of Care Testing
Point of care testing includes medical diagnostic tests that can be done at the time and place of patient care instead of being sent to a medical laboratory.
-
-
Chi-Ming Chow, M.D., MSc, FRCPC, FACC, FASE, attending staff cardiologist, St. Michael's Hospital, and associate professor, Department of Medicine, University of Toronto, discusses new technology...
-
GE Healthcare unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend. From the hospital and ambulance to more rural environments, Vscan Extend uses high image quality...
-
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies he found at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 meeting...
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S. Food and Drug Administration (FDA) is updating its November 2017 safety communication to...
News | Point of Care Testing | August 05, 2019
August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of...
News | Blood Testing | September 07, 2017
September 7, 2017 — In July, The Heart Institute at Florida Medical Center became the first hospital in the state of...
News | Point of Care Testing | July 26, 2017
July 26, 2017 — Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of...
News | Point of Care Testing | July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is...
Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.
Feature | Point of Care Testing | May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on...
News | Blood Testing | April 05, 2017
April 5, 2017 — PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded...
Technology | Point of Care Testing | January 27, 2017
January 27, 2017 — HyperMed Imaging Inc. announced that it has received clearance from the U.S. Food and Drug...
Technology | Blood Pressure Monitor | January 17, 2017
January 17, 2017 — The new SunTech Oscar 2 24-hour ambulatory...
Technology | Ultrasound Imaging | January 12, 2017
January 12, 2017 — GE Healthcare unveiled its new generation of pocket-sized, dual-probe...
News | Atrial Fibrillation | January 04, 2017
January 4, 2017 — A smartphone application made it possible to use the iPhone camera to detect atrial fibrillation...
The Xprecia Stride Coagulation Analyzer delivers fast, reliable prothrombin time/international normalized ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist. It is the latest INR testing system to enter the market in late 2016. Read the article “Siemens Receives FDA Clearance of Xprecia Stride Coagulation Analyzer.”
Feature | Point of Care Testing | December 30, 2016 | Ravi Chawat
Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology...
Feature | Point of Care Testing | December 07, 2016
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the...
Videos | TCT | November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology...
